Sign in

CIK 0001582554

  • Non-accelerated filer
  • Smaller reporting company

Matinas BioPharma Holdings, Inc.

Sign in to watch
Ticker
MTNB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463011414
Phone
+1 908-484-8805
Business address
1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
  1. 4 Grant or award Director acquired 6,994 shares (grant or award)
  2. 4 Other acquisition President and CEO acquired 3,000 shares (other)
  3. 4 Open-market buy Chief Financial Officer bought 94,500 shares at an average $1.22 ($114,968)
  4. 4 Open-market buy Director bought 100,000 shares at $1.06 ($105,530)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Other acquisition Director acquired 2,400 shares (other)
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Director acquired 38,066 shares (grant or award)
  12. 4 Grant or award Director acquired 25,179 shares (grant or award)
  13. 4 Conversion Director acquired 200,000 shares (conversion)
  14. 4 Grant or award Director acquired 29,739 shares (grant or award)
  15. 4 Open-market buy Director bought 20,000 shares at $0.66 ($13,200)
  16. 4 Open-market buy President and CEO bought 14,650 shares at $0.68 ($9,975)
  17. 4 Open-market buy Director bought 20,000 shares at $0.68 ($13,650)
  18. 4 Open-market buy Director bought 10,400 shares at $0.70 ($7,268)
  19. 4 Open-market buy Director bought 100,000 shares at $0.72 ($71,850)
  20. 4 Grant or award Director acquired 21,879 shares (grant or award)

Page 7 of 12 · 232 filings